EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders

View source ↗

Summary

EMA recommends measures to minimize serious side effects associated with Janus kinase inhibitors used for chronic inflammatory disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Disorders

Drugs mentioned

• Janus Kinase Inhibitors